Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish...

Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of “Don't Get Old. Age Better.®,” a new...

Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent launch of Fluvoxamine Maleate Extended-Release Capsules in 100 mg and...

Cronus Pharma LLC, a fully integrated animal health company, announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the...

Packaging Compliance Labs (PCL) is making a significant move into the pharmaceutical testing market by investing in a dedicated cGMP pharma lab and state-of-the-art capital...

o, the leading direct-to-patient healthcare company, announced a research collaboration with Novo that will generate first-of-its-kind real-world evidence on the Wegovy® pill. The debut research from...

Cresilon Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the launch of TRAUMAGEL®'s next generation, which officially debuts at EMS World...

Changes to customs procedures could affect some pathways used by Americans to obtain lower-cost prescription medications. The industry experts at SHARx, a supply-chain and procurement management company,...

Zifo, a global enabler of AI and data-driven enterprise informatics for science-driven organizations, unveiled its vision for an AI-driven scientific semantic layer, a dynamic framework designed to...

ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the appointment of Peter Olagunju as...

LEVEL, a science-driven cannabinoid company, announced results from an independent 29-day real-world study of its Relief Protab, conducted in partnership with third-party research firm MoreBetter. Across...

Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label for WINREVAIR™ (sotatercept-csrk)...